Table 4.
Efficacy and safety comparative analysis between FRED and FRED Junior devices
| Variables | FRED | FRED Junior | P values |
| n=149 (%) | n=36 (%) | ||
| Clinical outcome | |||
| mRS 3–6 | 0 | 1 (2.8) | |
| mRS 2 | 2 (1.3) | 1 (2.8) | |
| mRS 0–1 | 147 (98.7) | 34 (94.4) | 0.102 |
| Adverse events | |||
| Major complications | 7 (4.7) | 5 (13.9) | |
| Minor complications | 10 (6.7) | 0 | 0.045 |
| OKM grade C–D* | |||
| Total | 104 (87.5) | 28 (83.9) | 0.612 |
| Follow-up >1 year | 81 (92%) | 20 (95.2) | 0.614 |
*In 156 cases with arterial monitoring data.
mRS, modified Rankin Scale; OKM, O’Kelly–Marotta.